SEC Form 4 · accession 0001493152-18-009908
Adhera Therapeutics, Inc. · ATRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Uli Hacksell
Director
Period of report
Jul 10, 2018
Accepted (ET)
Jul 11, 2018 · 7:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000737207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stockF1 | $0.66 | Jul 10, 2018 | A | 1,000,000 | A | — | Jul 10, 2028 | common stock | 1,000,000 | 1,000,000 | D |
Explanation of responses
- F1Options to purchase 500,000 shares of common stock are exercisable immediately, options to purchase 125,000 shares of common stock are exercisable on each of July 1, 2019 and July 1, 2020, options to purchase 125,000 shares of common stock shall vest on such date, if any, as the Issuer pays to the reporting person a bonus in the amount of $25,000 if the Issuer achieves net product revenue in the amount of not less than $1.2 million for the portion of the 2018 fiscal year following July 1, 2018, and options to purchase 125,000 shares of common stock shall vest on such date, if any, as the Issuer pays to the reporting person a bonus in the amount of $25,000 if the daily VWAP of the common stock of the Issuer is not less than $2.00 per share for a sixty consecutive day period beginning on any calendar day during the 2018 fiscal year on or after July 1, 2018.